Idelalisib
Phosphatidylinositol-3-Kinase (Pi3k) Inhibitors
Sold as ZYDELIG
- Drug class
- Phosphatidylinositol-3-Kinase (Pi3k) Inhibitors
- Availability
- See label
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 5
Overview
Idelalisib is an active pharmaceutical ingredient in the Phosphatidylinositol-3-Kinase (Pi3k) Inhibitors group (L01EM). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | December 19, 2025 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
| EU European Union | EMA | 1 | October 21, 2024 |
GBUnited Kingdom· MHRA
2 products
Uses
4). 4).
How to take
CACanada· Health Canada
2 products
Uses
AND CLINICAL USE ....................................................................................... 3 CONTRAINDICATIONS ........................................................................................................ 4 WARNINGS AND PRECAUTIONS ........................................................................................
5 ADVERSE REACTIONS ....................................................................................................... 10 DRUG INTERACTIONS.......................................................................................................
17 DOSAGE AND ADMINISTRATION ..................................................................................... 18 OVERDOSAGE...................................................................................................................
21 ACTION AND CLINICAL PHARMACOLOGY ........................................................................ 21 STORAGE AND STABILITY ................................................................................................. 24 SPECIAL HANDLING INSTRUCTIONS.................................................................................
EUEuropean Union· EMA
1 product
Uses
4). 4).
How to take
Drug interactions
Known interactions involving Idelalisib. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PLGB119720032 · revised December 19, 2025
- [2]Health Canada (DPD) · 02438798 · revised March 22, 2025
- [3]European Medicines Agency · EMEA/H/C/003843 · revised October 21, 2024
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.